DIKUL - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov UL. Za polni dostop se PRIJAVITE.

28 29 30
zadetkov: 291
291.
  • Phase I Dose-escalation and... Phase I Dose-escalation and Pharmacokinetic Trial of Lapatinib (GW572016), a Selective Oral Dual Inhibitor of ErbB-1 and -2 Tyrosine Kinases, in Japanese Patients with Solid Tumors
    Nakagawa, Kazuhiko; Minami, Hironobu; Kanezaki, Masayuki ... Japanese journal of clinical oncology, 02/2009, Letnik: 39, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    Objective The Phase I dose-escalation study was conducted to evaluate the safety and pharmacokinetics of lapatinib (GW572016), a dual ErbB-1 and -2 inhibitor, in Japanese patients with solid tumors ...
Celotno besedilo
Dostopno za: UL

PDF

Nalaganje filtrov